AFT Pharmaceuticals Limited (NZX:AFT), CRG and Atkinson Family Trust has declared to raise capital to reduce debt and increase liquidity.
The underwritten placement which will be undertaken by the company comprises of:
- a primary placement which shall raise about NZ$ 10 million by issuing new shares in the company;
- a secondary sale of about 16 million current shares by CRG and about NZ$ 3.5 million worth of shares by AF Trust.
The website has been prepared for informational purposes only and is not intended to be used as a complete source of information on any particular company. The above article is NOT a solicitation or recommendation to buy, sell or hold the stock of the company (or companies) under discussion. Kalkine does not in any way endorse or recommend individuals, products or services that may be discussed on this site.